ARMRA Colostrum Revenue and Competitors
Estimated Revenue & Valuation
- ARMRA Colostrum's estimated annual revenue is currently $12.6M per year.
- ARMRA Colostrum's estimated revenue per employee is $140,000
Employee Data
- ARMRA Colostrum has 90 Employees.
- ARMRA Colostrum grew their employee count by 150% last year.
ARMRA Colostrum's People
Name | Title | Email/Phone |
---|---|---|
1 | Head Operations | Reveal Email/Phone |
2 | Head CX | Reveal Email/Phone |
3 | Head Process | Reveal Email/Phone |
4 | Head Brand | Reveal Email/Phone |
5 | Head Finance | Reveal Email/Phone |
6 | Head Wholesale & Retail | Reveal Email/Phone |
7 | Head People | Reveal Email/Phone |
8 | Director Logistics | Reveal Email/Phone |
9 | Sr. Director Influencers | Reveal Email/Phone |
10 | Director Community Relations | Reveal Email/Phone |
ARMRA Colostrum Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $17.4M | 124 | 1450% | N/A | N/A |
#2 | $7.1M | 51 | 11% | N/A | N/A |
#3 | $90.4M | 646 | 24% | N/A | N/A |
#4 | $9.2M | 66 | 32% | N/A | N/A |
#5 | $12.6M | 90 | 150% | N/A | N/A |
What Is ARMRA Colostrum?
Modern living breaks down your immune barrier. \nARMRA™ Colostrum is the first bioactive food that builds it back.\n\nWe’re rebuilding health from the inside out. At ARMRA, we use never-been-done, Cold-Chain BioPotent™ technology, and leverage immune intelligence to protect, restore, and enhance complete immune health and cellular performance. Harnessing the power of colostrum and its 200+ bioactive nutrients, we bring together technology and superfood science, empowering you to face the modern world head on.\n\nWe're ARMRA. The revival of health.
keywords:N/AN/A
Total Funding
90
Number of Employees
$12.6M
Revenue (est)
150%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 90 | 67% | N/A |
#2 | $13.3M | 92 | 5% | $40.2M |
#3 | $15.6M | 92 | 0% | N/A |
#4 | $16M | 92 | 7% | N/A |
#5 | $21.4M | 94 | 7% | N/A |